Distribution of HPV infection and tumour markers in cervical intraepithelial neoplasia from cone biopsies of Mozambican women

Journal of Clinical Pathology

Volumn 58, Issue 1, 2005, Pages 61-68

  Carrilho, C ^a,b   Cirnes, L ^a   Alberto, M ^b   Buane, L ^b   Mendes, N ^a   David, L ^a,b,c  

^a UNIVERSITY OF PORTO   (Portugal)

^b MAPUTO CENTRAL HOSPITAL   (Mozambique)

^c University of Porto   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOHYDRATE; CYTOKERATIN; CYTOKERATIN 17; CYTOKERATIN 8; GLYCOPROTEIN; GLYCOPROTEIN GP 230; KI 67 ANTIGEN; PROTEIN P53; TUMOR MARKER; UNCLASSIFIED DRUG;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME IMMUNOASSAY; FEMALE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 33; HUMAN PAPILLOMAVIRUS TYPE 35; HUMAN PAPILLOMAVIRUS TYPE 38; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MOZAMBIQUE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; UTERINE CERVIX; UTERINE CERVIX BIOPSY; UTERINE CERVIX CARCINOMA IN SITU; VIRUS INFECTION; WART VIRUS;

BIOPSY; CERVICAL INTRAEPITHELIAL NEOPLASIA; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; KERATINS; KI-67 ANTIGEN; MOZAMBIQUE; NEOPLASM PROTEINS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53; UTERINE CERVICAL NEOPLASMS;

EID: 11244292359     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.2004.020552     Document Type: Article

References (38)

1. Bosch FX, Lorincz A, Munoz N, et al. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 2002;55:244-65.
2. Carrilho C, Gouveia P, Cantel M, et al. Characterization of human papillomavirus infection, P53 and Ki-67 expression in cervix cancer of Mozambican women. Pathol Res Pract 2003;199:303-11.
3. Castellsague X, Menendez C, Loscertales MP, et al. Human papillomavirus genotypes in rural Mozambique. Lancet 2001;358:1429-30.
4. Mayaud P, Weiss HA, Lacey CJ, et al. Genital human papillomavirus genotypes in northwestern Tanzania. J Clin Microbiol 2003;41:4451-3.
5. Thomas JO, Herrero R, Omigbodun AA, et al. Prevalence of papillomavirus infection in women in Ibadan, Nigeria: a population-based study. Br J Cancer 2004;90:638-45.
6. Xi LF, Toure P, Critchlow CW, et al. Prevalence of specific types of human papillomavirus and cervical squamous intraepithelial lesions in consecutive, previously unscreened, West-African women over 35 years of age. Int J Cancer 2003;103:803-9.
7. Bosch FX, Muñoz N, de Sanjosé S, et al. Human papillomavirus and cervical intraepithelial neoplasia grade III/carcinoma in situ: a case control study in Spain and Colombia. Cancer Epidemiol Biomarkers Prev 1993;2:415-22.
8. Schiffman MH, Bauer HM, Hoover RN, et al. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J Natl Cancer Inst 1993;85:958-64.
9. Cuschieri KS, Cubie HA, Whitley MW, et al. Multiple high risk HPV infections are common in cervical neoplasia and young women in a cervical screening population. J Clin Pathol 2004;57:60-72.
10. Gravitt PE, Peyton CL, Alessi TQ, et al. Improved amplification of genital human papillomavirus. J Clin Microbiol 2000;38:357-61.
11. Quint WGV, Scholte G, van Doom LJ, et al. Comparative analysis of human papillomavirus infections in cervical scrapes and biopsy specimens by general SPF10 PCR and HPV genotyping. J Pathol 2001;194:51-8.
12. Bekkers RL, Melchers WJ, Bulten J, et al. Localized distribution of human papillomavirus genotypes in the uterine cervix. Eur J Gynaecol Oncol 2002;23:203-6.
13. Park JP, Sun D, Genest DR, et al. Coexistence of low and high grade squamous intraepithelial lesions of the cervix: morphologic progression or multiple papillomaviruses? Gynecol Oncol 1998;70:386-91.
14. Scully RE, Bonfiglio TA, Kurman RJ, et al. World Health Organisation: histological typing of the female genital tract tumors. Berlin: Springer Verlag, 1994.
15. Kjeldsen T, Clausen H, Hirohashi S, et al. Preparation and characterization of monoclonal antibodies directed to the tumor-associated O-linked sialosyl-2→6 α-N-acetylgalactosaminyl (sialosyl-Tn) epitope. Cancer Res 1988;48:2214-20.
16. Clausen H, Stroud M, Parker J, et al. Monoclonal antibodies directed to the blood group A associated structure, galatosyl-A: specificity and relation to the Thomsen-Friedenreich antigen. Mol Immunol 1988;25:199-204.
17. Nielsen PA, Mandel U, Therkildsen MH, et al. Loss of a mucin-like epithelial glycoprotein in oral and cervical squamous cell carcinomas. Cancer Res 1997;57:634-40.
18. Hsu SM, Raine L, Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques. A comparison between ABC and unlabeled antibody (PAP) procedures. J Histocnem Cytochem 1981;29:577-80.
19. Smedts F, Ramaekers F, Link M, et al. Detection of keratin subtypes in routinely processed cervical tissue: implications for tumour classifications and the study of cervix cancer aetiology. Virchows Arch 1994;425:145-55.
20. Carrilho C, Cantel M, Gouveia P, et al. Simple mucin-type carbohydrate antigens (Tn, sialosyl-Tn, T and sialosyl-T) and gp 230 mucin-like glycoprotein are candidate markers for neoplastic transformation of the human cervix. Virchows Arch 2000;437:173-9.
21. Jacobs MV, van den Brule AJC, Snijders PJF, et al. A non-radioactive PCR enzyme-immunoassay enables a rapid identification of HPV 16 and 18 in cervical scrapes after GP5+/6+ PCR. J Med Virol 1996;49:223-9.
22. Jacobs MV, Snijders PJF, van den Brule AJC, et al. A general primer GP5+/ GP6+-mediated PCR-enzyme-immunoassay method for rapid detection of 14 high-risk and 6 low-risk human papillomavirus genotypes in cervical scrapings. J Clin Microbiol 1997;35:791-5.
23. Levy JE, Fernandes S, Tateno AF, et al. Presence of multiple human papillomavirus types in cervical samples from HIV-infected women. Gynecol Oncol 2004;92:225-31.
24. Kuhn L, Denny L, Pollack A, et al. Human papillomavirus DNA testing for cervical cancer screening in low-resource settings. J Natl Cancer Inst 2000;92:818-25.
25. Muñoz N, Bosch FX, Castellsagué X, et al. Against which human papillomavirus types shall we vaccinate and screen? The international perspective. Int J Cancer 2004;111:278-85.
26. Riou G, Favre M, Jeannel D, et al. Association between poor prognosis in early-stage invasive cervical carcinomas and non-detection of HPV-DNA. Lancet 1990;335:1171-4.
27. Iwasaka T, Hayashi Y, Yokoyama M, et al. "Hit and run" oncogenesis by human papillomavirus type 18 DNA. Acta Obstet Gynecol Scand 1992;71:219-23.
28. Morgan D, Pecoraro G, Rosenberg I, et al. Human papillomavirus type 6b DNA required for initiation but not maintenance of transformation of C127 mouse cells. J Virol 1990;64:969-76.
29. Lechner MS, Laimins LA. Inhibition of p53 DNA binding by human popillomavirus E6 proteins. J Virol 1994;68:4262-73.
30. Bar JK, Harlozinska A, Sedlaczek P, et al. Relations between the expression of P53, c-erbB-2, ki-67 and HPV infection in cervical carcinomas and cervical dysplasias. Anticancer Res 2001;21:1001-6.
31. Hietala KA, Kosma VM, Syrjanen KJ, et al. Correlation of MIB-1 antigen expression with transcription factors Skn-1, Oct-1, AP-2, and HPV type in cervical intraepithelial neoplasia. J Pathol 1997;183:305-10.
32. Kruse AJ, Baak JP, de Bruin PC, et al. Relationship between the presence of oncogenic HPV DNA assessed by polymerase chain reaction and Ki-67 immunoquantitative features in cervical intraepithelial neoplasia. J Pathol 2001;195:557-62.
33. Mittal KR, Lin O, Chan W, et al. Cervical squamous dysplasias and carcinomas with immunodetectable p53 frequently contain HPV. Gynecol Oncol 1995;58:289-94.
34. Carrilho C, Alberto M, Buane L, et al. Keratins 8, 10, 13, and 17 are useful markers in the diagnosis of human cervix carcinomas. Hum Pathol 2004;35:546-51.
35. Maddox P, Sasieni P, Szarewski A, et al. Differential expression of keratins 10, 17, and 19 in normal cervical epithelium, cervical intraepithelial neoplasia, and cervical carcinoma. J Clin Pathol 1999;52:41-6.
36. Raju GC. Expression of the cytokeratin marker CAM 5.2 in cervical neoplasia. Histopathology 1988;12:437-43.
37. Martens J, Baars J, Smetds F, et al. Can keratin 8 and 17 immunohistochemistry be of diagnostic value in cervical cytology? A feasibility study. Cancer 1999;87:87-92.
38. Terosawa K, Furumoto H, Kamada M, et al. Expression of Tn and sialyl-Tn antigens in the neoplastic transformation of the uterine cervical epithelial cells. Cancer Res 1996;56:2229-32.